Trial intelligence / Profile preview

Morphine for refractory dyspnoea

ACTRN12607000075482Phase 3Completed

Sponsor
Repatriation General Hospital
Start
Apr 2001
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of morphine hydrochloride, sponsored by Repatriation General Hospital. Started Apr 2001; status: completed.

02

Drugs

morphine hydrochloride

Beyond the preview

Go deeper on ACTRN12607000075482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12607000075482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call